Medicalg (MDG) - Total Assets
Based on the latest financial reports, Medicalg (MDG) holds total assets worth zł111.36 Million PLN (≈ $30.65 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check MDG total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Medicalg - Total Assets Trend (2010–2024)
This chart illustrates how Medicalg's total assets have evolved over time, based on quarterly financial data. Explore MDG long-term investment intensity to see how much of total assets are deployed in long-term investments.
Medicalg - Asset Composition Analysis
Current Asset Composition (December 2024)
Medicalg's total assets of zł111.36 Million consist of 21.1% current assets and 78.9% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 5.2% |
| Accounts Receivable | zł7.47 Million | 7.1% |
| Inventory | zł9.39 Million | 8.9% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł59.50 Million | 56.2% |
| Goodwill | zł18.97 Million | 17.9% |
Asset Composition Trend (2010–2024)
This chart illustrates how Medicalg's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see MDG market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medicalg's current assets represent 21.1% of total assets in 2024, a decrease from 56.4% in 2010.
- Cash Position: Cash and equivalents constituted 5.2% of total assets in 2024, up from 0.0% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 73.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is intangible assets at 56.2% of total assets.
Medicalg Competitors by Total Assets
Key competitors of Medicalg based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
|
China | CN¥3.54 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
Medicalg - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.11 | 1.76 | 1.14 |
| Quick Ratio | 0.78 | 1.08 | 1.62 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł1.73 Million | zł8.61 Million | zł6.91 Million |
Medicalg - Advanced Valuation Insights
This section examines the relationship between Medicalg's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.35 |
| Latest Market Cap to Assets Ratio | 0.70 |
| Asset Growth Rate (YoY) | -13.0% |
| Total Assets | zł105.81 Million |
| Market Capitalization | $74.23 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medicalg's assets below their book value (0.70x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Medicalg's assets decreased by 13.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Medicalg (2010–2024)
The table below shows the annual total assets of Medicalg from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | zł105.81 Million ≈ $29.12 Million |
-13.00% |
| 2023-12-31 | zł121.63 Million ≈ $33.47 Million |
+11.86% |
| 2022-12-31 | zł108.74 Million ≈ $29.93 Million |
-4.96% |
| 2021-12-31 | zł114.41 Million ≈ $31.49 Million |
-59.63% |
| 2020-12-31 | zł283.40 Million ≈ $78.00 Million |
+0.05% |
| 2019-12-31 | zł283.26 Million ≈ $77.96 Million |
-10.38% |
| 2018-12-31 | zł316.08 Million ≈ $86.99 Million |
+9.26% |
| 2017-12-31 | zł289.28 Million ≈ $79.61 Million |
-21.79% |
| 2016-12-31 | zł369.89 Million ≈ $101.80 Million |
+261.69% |
| 2015-12-31 | zł102.27 Million ≈ $28.15 Million |
+7.77% |
| 2014-12-31 | zł94.89 Million ≈ $26.12 Million |
+13.63% |
| 2013-12-31 | zł83.51 Million ≈ $22.98 Million |
+10.49% |
| 2012-12-31 | zł75.58 Million ≈ $20.80 Million |
+461.90% |
| 2011-12-31 | zł13.45 Million ≈ $3.70 Million |
+265.99% |
| 2010-12-31 | zł3.68 Million ≈ $1.01 Million |
-- |
About Medicalg
Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. It offers PocketECG, an AI-driven online ECG monitoring device for long-term holter, cardiac event, and mobile cardiac telemetry analysis; Kardiobeat.ai, an AI-Driven lightweight wireless holter monitor; DeepRhythm Platform, a hardware-agnostic cloud-based software that leverages cuttin… Read more